Empire Analyst: Sell Sucampo Pharma, It Has 50% Downside By: Benzinga via Benzinga January 12, 2016 at 10:45 AM EST Amid volatility, Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) shares have declined 21 percent over the past six ... Read More >> Related Stocks: Allergan Plc Astrazeneca Plc ADR Daiichi Sankyo Ltd ADR Ironwood Pharmaceuti Progenics Pharmaceuticals Shionogi & Ltd Un ADR Synergy Pharma Valeant Pharmaceuticals International, Inc.